Organon (NYSE:OGN) reported quarterly earnings of $0.87 per share which missed the analyst consensus estimate of $0.90 by 3.33 percent. The company reported quarterly sales of $1.58 billion which beat the analyst consensus estimate of $1.56 billion by 1.31 percent. This is a 4.15 percent increase over sales of $1.52 billion the same period last year.